Dyne Therapeutics, Inc.

Dyne Therapeutics, Inc. financial statements

Dyne Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 446.21M10-K
Cash and equivalentsUSD 893.37M10-Q
Total debtUSD 148.92M10-Q

Dyne Therapeutics, Inc. financials on 6ix · Dyne Therapeutics, Inc. on 6ix